Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathwaysFrancesca Bruzzese, Alfredo Budillon, Alessandra Leone et al.|Cell Death and Disease|2013Cited by 57
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylaseElena Di Gennaro, Alfredo Budillon, Geny Piro et al.|British Journal of Cancer|2010Cited by 49
Abstract 3650: <i>In Vitro and in vivo synergistic anticancer effect of HDAC inhibitor panobinostat (LBH589) plus zoledronic acid in human prostate, breast and multiple myeloma tumor models</i>Monia Rocco, Alfredo Budillon, Francesca Bruzzese et al.|Cancer Research|2010Cited by 0
Abstract 5442: <i>In vitro</i> and <i>in vivo</i> upregulation of thymidine phosphorylase expression in colon cancer cells by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with capecitabineElena Di Gennaro, Alfredo Budillon, Maria Chianese et al.|Cancer Research|2010Cited by 0